The Bioproduction 2016, will be held in Mumbai, India from June 9-10th 2016, where experts from Asia Pacific and other countries will be presenting topics all areas of BioProduction such as as formulation, development, production, regulatory
The conference will provide a platform for the key Biologic manufacturers from across Asia-pacific and rest of the world to share technological innovations, discuss the challenges and explore practical solutions for best practices in Bio-therapeutics development and production where experts from all areas of Bio production from Asia-pacific will be attending. It will include presentations and case studies from leading Industry experts and Academic research.
The main topics will include
- Downstream processing
- Upstream Processing
- Discover the Recent Advances, technology and strategy approaches that can accelerate the pace and improve the efficiency of biopharmaceutical development and production
- Scaling up and down – Modelling to manufacturing
- Integrated Continuous Processing for the Manufacture of Monoclonal Antibodies
- Purification technologies
- Bioreactor design and engineering
- Process analytical techniques and QBD
- Single use, change and Quality control
- Novel analytical technologies for the next generation of bio therapeutics
- Emerging technologies for drug product manufacturing
- Cell Therapy Development, Production & Commercialization
- Regulatory pathways for approval
- Bioproduction of Antibodies, vaccines, proteins, cell, gene and immunotherapies, Biosimilars, monoclonal antibodies.
In addition to the conference, there will be training/worshop organised on 9th June 2016 on Single use technologies, DOE and Statistics approach for Product development and process characterization,Current Challenges in Mammalian Cell Processing, Single Use technology for BioManufacturing, Quality by design for effective Bio-process characterization and Validation
Over 200 professionals, end users Biotherapeutics development & Prodcution from leading pharma and Biotechnology companies such as Cipla, Biocon,Novartis,USV, Relaince lifesciences, Ferring pharmaceuticals, Mylan, Serum Institute, Biological E, Aurobindo Pharma,Emcure, Dr Reddys, Panacea Biotech, Shantha, Hospira, Fresenius Kabi, Gland Pharma will be attending.
WHO SHOULD ATTEND
Designations
Vice Presidents . CEOs . Directors of R&D . Process Development Scientist & Engineers . Head of QA . Project & Product Manager . Researchers . Purification Technicians . Operations Director . Plant Manager . Vaccine Production, Team Leaders, and Senior Scientists from Biopharmaceutical, Biotechnology, Biomedical Engineering, Diagnostic Industries
Departments
Upstream Processing . Downstream Processing . Bioprocess R&D . Cell Culture Engineering . Quality Assurance & Control . Commercial Manufacturing . Regulatory Affairs & Compliance . Technical Operations & Tech Transfer
BENEFITS OF ATTENDING
- Gain insights from expert
- Hear about the latest
- Developments
- Explore best practices from
- Industry experts
- Regulatory updates and development
- Expand your professional Network
- Evaluate the latest tools & Services from cutting edge Vendors
For more information, please visit the event website here.
Mumbai, India | June 9 - 10, 2016